怀孕期间的癌症诊断与严重的孕产妇和新生儿死亡率有关
Alexa Kanbergs1, Mark Clapp2, Chi-Fang Wu3
1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
American journal of obstetrics and gynecology
|October 24, 2024
概括
怀孕期间的癌症显著增加了严重的孕产妇死亡率,早产和新生儿并发症的风险. 对于这些高风险怀孕,谨慎管理至关重要.
科学领域:
- 产科和妇科 产科和妇科
- 在瘤学瘤学.
- 围产儿医学 围产儿医学
背景情况:
- 关于因癌症而复杂的怀孕对母亲和胎儿的结果的数据有限.
- 越来越多的妇女在怀孕期间被诊断出患有癌症,需要对结果进行评估.
研究的目的:
- 评估怀孕期间诊断出早期妇科或乳腺癌的妇女的产科结果.
- 将这些结果与没有癌症的女性相匹配的队列进行比较.
主要方法:
- 基于人口的研究,使用加利福尼亚癌症登记 (2000-2012) 和出生数据.
- 包括18-45岁的女性,患有I期妇科或I-III期乳腺癌,在诊断后10个月内分娩.
- 使用倾向分数匹配对照 (2:1);分析了严重的孕产妇病率,早产和新生儿病率.
主要成果:
- 分析了503名怀孕期间患有癌症的妇女 (乳腺,卵巢,宫) 和1006名对照.
- 怀孕期间的癌症与严重的孕产妇死亡率 (OR 8.03),早产 (32-36周,OR 5.38) 和新生儿死亡率 (OR 2.22) 的几率明显更高.
- 在癌症在怀孕组中观察到子宫切除和败血症的增加率.
结论:
- 由于癌症导致的妊娠并发症与孕产妇和新生儿发病率的风险增加有关.
- 这些发现强调了专门管理和密切监测癌症孕妇妇产科结果的重要性.
相关概念视频
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Disorders of the Female Reproductive System
332
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
332
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Psychoneuroimmunology: Diabetes and Cancer
24
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
24
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K


